Portfolio (Quarterly)
Guide ↗
China Universal Asset Management Co., Ltd.
· CIK 0001906594| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 161 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 16,518.0 | $313K | 0.02% | +3K | +23.3% | $18.97 | -7.7% |
| 162 | GMAB | GENMAB A/S -SP ADR | Healthcare | 9,525.0 | $293K | 0.02% | +2K | +29.6% | $30.80 | -12.8% |
| 163 | PHVS | PHARVARIS NV | Healthcare | 10,438.0 | $290K | 0.02% | +7K | +247.9% | $27.75 | +7.0% |
| 164 | INVA | INNOVIVA INC | Healthcare | 12,184.0 | $244K | 0.02% | +1K | +10.3% | $19.99 | +12.4% |
| 165 | QURE | UNIQURE NV | Healthcare | 10,150.0 | $243K | 0.02% | +533.0 | +5.5% | $23.93 | +1.1% |
| 166 | PGEN | PRECIGEN INC | Healthcare | 57,656.0 | $241K | 0.02% | +5K | +10.4% | $4.18 | +1.4% |
| 167 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 7,888.0 | $239K | 0.02% | +1K | +20.1% | $30.31 | +100.0% |
| 168 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 17,895.0 | $216K | 0.02% | +2K | +14.5% | $12.08 | +12.4% |
| 169 | — | DEFINIUM THERAPEUTICS INC | — | 16,052.0 | $215K | 0.02% | +3K | +20.4% | $13.39 | — |
| 170 | SVRA | SAVARA INC | Healthcare | 33,155.0 | $200K | 0.01% | +3K | +9.4% | $6.03 | -16.7% |
| 171 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 21,946.0 | $194K | 0.01% | +2K | +12.5% | $8.86 | +128.4% |
| 172 | ANNX | ANNEXON INC | Healthcare | 36,084.0 | $181K | 0.01% | +823.0 | +2.3% | $5.02 | +5.8% |
| 173 | IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | 64,686.0 | $177K | 0.01% | +1K | +2.0% | $2.73 | +50.5% |
| 174 | ESPR | ESPERION THERAPEUTICS INC | Healthcare | 38,955.0 | $144K | 0.01% | +4K | +10.2% | $3.70 | -15.4% |
| 175 | CRVS | CORVUS PHARMACEUTICALS INC | Healthcare | 18,169.0 | $140K | 0.01% | +5K | +39.1% | $7.70 | +63.8% |
| 176 | ABSI | ABSCI CORP | Healthcare | 34,503.0 | $120K | 0.01% | +8K | +31.6% | $3.49 | +46.1% |
| 177 | LXEO | LEXEO THERAPEUTICS INC | Healthcare | 11,893.0 | $118K | 0.01% | +2K | +25.6% | $9.93 | -48.5% |
| 178 | LYEL | LYELL IMMUNOPHARMA INC | Healthcare | 3,457.0 | $106K | 0.01% | +90.0 | +2.7% | $30.78 | -43.3% |
| 179 | IMRX | IMMUNEERING CORP - CLASS A | Healthcare | 15,522.0 | $102K | 0.01% | +11K | +210.4% | $6.58 | -18.1% |
| 180 | SLN | SILENCE THERAPEUTICS PLC-ADR | Healthcare | 13,653.0 | $83K | 0.01% | +5K | +65.8% | $6.08 | +2.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
39.5%
Healthcare
21.2%
Communication Services
12.4%
Financial Services
10.6%
Consumer Cyclical
10.1%
Consumer Defensive
2.7%
Industrials
1.9%
Utilities
0.6%
Basic Materials
0.5%
Energy
0.4%